Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Functional cofactors for targeted modification of biomolecules

Project description

Expanding methylation tools for medicine

Methylation is a fundamental biochemical process that adds a methyl group to various biomolecules, including DNA and proteins. Methylation regulates gene expression and has broad implications for cellular function. Abnormal methylation of DNA, RNA or histones can cause developmental defects and has been linked to various diseases. The ERC-funded CoMBi project focuses on methyltransferase enzymes, which carry out the biological methylation reactions and can be engineered to transfer enlarged chemical groups from synthetic donor analogs. The aim is to overcome existing limitations associated with the availability of these enlarged group donors which serve as tools for functional modification of biomolecules. Researchers plan to optimise protocols for industrial production of these valuable reagents ensuring their broad accessibility for research and clinical applications.

Objective

Enzymatic addition of a methyl group (methylation) is the most prevalent natural modification in cells, serving a myriad of regulatory and structural functions. Abnormal methylation of DNA, RNA or histone proteins can lead to severe developmental defects and is associated with numerous human diseases. Selective methylation of biomolecular targets is carried out by dedicated methyltransferase enzymes, which use the cofactor S-adenosyl-L-methionine (AdoMet) as the source of methyl groups. Despite the high specificity and impressive diversity of MTases, the deposited methyl groups are poor reporters and hardly amenable to further derivatization. To unlock the biotechnological power of MTases, strategies for repurposing these enzymes into targeting vehicles for the transfer of useful extended groups from synthetic AdoMet analogs have been devised. However, despite substantial advances over the past decade, a widespread adoption of this enabling technology in scientific labs and clinical settings was grossly hindered by the poor availability of such synthetic cofactors. This proposal, footed on findings of our ERC-funded work, will seek to overcome the limitations of chemical synthesis and adapt our recently developed chemo-enzymatic protocols for low-cost industrial production of functionally competent AdoMet analogs. We will also seek the transfer of the technology to an industrial partner for its commercial exploitation and to ensure broad access of these valuable reagents to the scientific community and commercial stakeholders.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-POC

See all projects funded under this call

Host institution

VILNIAUS UNIVERSITETAS
Net EU contribution
€ 150 000,00
Address
UNIVERSITETO G. 3
01513 Vilnius
Lithuania
Region
Lietuva Sostinės regionas Vilniaus apskritis
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)